Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report.

Dupilumab is a monoclonal antibody targeting interleukin-4 and interleukin-13 for the treatment of moderate-to-severe atopic dermatitis.1 We report a case of occupational irritant hand dermatitis in a nonatopic individual that improved on dupilumab.